身体衰弱与心血管病风险的关联:血浆代谢组变化的中介作用
基于95 770名UK Biobank参与者的数据,研究构建了包含43种血浆代谢物的衰弱相关代谢组特征评分,并分析其与心血管病(CVD)、冠心病(CHD)和卒中的关联。中位随访13.81年显示,高代谢组评分与CVD(HR=1.44)、CHD(HR=1.50)和卒中(HR=1.45)风险升高显著相关;中介分析表明该代谢组特征解释了衰弱与CVD关联的14.9%、CHD的16.0%和卒中的16.9%。
要点
- 衰弱相关代谢组评分包含43种血浆代谢物,涵盖脂质、氨基酸、脂肪酸和能量代谢。
- 高代谢组评分显著增加CVD、CHD和卒中风险,HR分别为1.44、1.50和1.45。
- 代谢组特征部分介导衰弱与心血管病的关联,中介比例分别为14.9%、16.0%和16.9%。
核心结论
- 衰弱相关代谢组特征可独立预测心血管风险,并部分介导衰弱与CVD的关联。
研究设计与样本
- 基于95 770名UK Biobank参与者的队列研究,采用弹性网络正则化回归构建代谢组特征评分,中位随访13.81年。
主要发现
- 高代谢组评分与CVD风险增加相关(HR=1.44;95%CI:1.36-1.53)。
- 高代谢组评分与CHD风险增加相关(HR=1.50;95%CI:1.41-1.61)。
- 高代谢组评分与卒中风险增加相关(HR=1.45;95%CI:1.37-1.54)。
- 代谢组特征解释衰弱与CVD关联的14.9%、CHD的16.0%和卒中的16.9%。
- 通路富集分析发现7条代谢通路显著富集,主要涉及碳水化合物和氨基酸代谢。
关键数值与推荐
- 代谢组特征评分由43种血浆代谢物构成,涵盖脂质、氨基酸、脂肪酸和能量代谢。
- 中介分析采用反事实框架量化代谢组特征的中介比例。
临床怎么用
- 代谢组特征评分有助于早期识别衰弱相关心血管病高风险个体。
- 代谢组学分析可为衰弱相关心血管结局的预防策略提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frailty has been increasingly recognized as a significant contributor to adverse cardiovascular outcomes. However, the metabolic mechanisms underlying this relationship remain unclear. This study aimed to identify metabolomic signatures of frailty and their mediating roles in cardiovascular disease (CVD) risk. METHODS: Using data from 95 770 UK Biobank participants, we applied elastic net regularized regression to construct a frailty-related metabolomic signature score comprising 43 plasma metabolites across lipids, amino acids, fatty acids, and energy metabolism. Cox proportional hazards models were used to assess the association between this metabolomic signatures score and incident CVD, coronary heart disease (CHD), and stroke over a median follow-up of 13.81 years. Mediation analysis under a counterfactual framework was conducted to quantify the extent to which the metabolomic signatures mediated the frailty-CVD association. RESULTS: High metabolomic signature scores were significantly associated with increased risks of CVD (hazard ratio [HR] = 1.44; 95% confidence interval [CI]: 1.36-1.53), CHD (HR = 1.50; 95% CI: 1.41-1.61), and stroke (HR = 1.45; 95% CI: 1.37-1.54). Mediation analysis indicated that the metabolomic signature accounted for 14.9% of the association between frailty and overall CVD, 16.0% for CHD, and 16.9% for stroke. Pathway enrichment analysis revealed 7 metabolic pathways significantly enriched in frailty, with the primary associations implicating carbohydrate and amino acid metabolism. CONCLUSIONS: This study highlights a distinct frailty-related metabolic profile that independently predicts cardiovascular risk and partially mediates the frailty-CVD association. These findings underscore the value of metabolomic profiling in guiding early detection and prevention strategies for frailty-related cardiovascular outcomes.
引用
- Sun G, Yu L, Mahemuti N, et al. Associations of physical frailty with risk of incident cardiovascular disease by mediation of plasma metabolome changes. J Gerontol A Biol Sci Med Sci. 2026. PMID: 41693009. doi:10.1093/gerona/glag035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。